In February 2021, the US FDA approved Breyanzi (lisocabtagene maraleucel), a CAR T-cell therapy, as a treatment for DLBCL adult patients who have not responded to or relapsed after at least two lines of SOC.
▶️ 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐅𝐨𝐫 𝐑𝐞𝐩𝐨𝐫𝐭 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧:- https://lnkd.in/dvh8svjb
#chimeric_antigen_receptor_t_cell_therapy #antigen #chimeric #receptor #immunotherapy #cancer #bloodcancer #lymphoma #healthcare #marknteladvisors
Blacks Network – an interactive global social network platform gear towards recognizing the voice of the unheard around the world. Blacks Network stand to beat the world of racial discrimination and bias in our community. Get Involved! #BlacksNetwork
Engaged in business and social networking. Promote your brand; Create Funding Campaign; Post new Jobs; Create, post and manage marketplace. Start social groups and post events. Upload videos, music, and photos.
1 (877) 773-1002
